Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
The Danish drugmaker Novo Nordisk contends that semaglutide, the active ingredient in Ozempic and Wegovy, is too complex for ...
Acsh.org13h
The Anniversary of FDA's Landmark Approval of Genetically Engineered Human Insulin: A Cautionary Tale
Often, they do not. Next Tuesday, October 29 th, marks the 42nd anniversary of one of biotechnology's most significant ...
ENDPOINTS NEWS2h
No­vo Nordisk pe­ti­tions FDA to stop semaglu­tide com­pound­ing over safe­ty risks
Novo Nordisk is continuing its crusade against compounded versions of its blockbuster weight loss drugs by petitioning the ...
FDA says this weight loss drug shortage is over, but patients worry about cost and availability
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
Managed Healthcare Executive2h
FDA Approves Stelara Biosimilar Selardsi for Additional Formulation
This week’s approval expands Seldardsi indications to treat adults with Crohn’s disease and ulcerative colitis.
BioSpace55m
GLP-1 Prescriptions for Type 1 Diabetes Spike Despite Lack of FDA Approval: Study
While the regulator has not approved their use in type 1 diabetes, off-label prescribing for GLP-1 receptor agonists has ...
Richmond1h
New FDA rules require plain language for mammograms
In September, the U.S. Food and Drug Administration released new rules that require a summary be sent directly to patients ...
FDA and CBP Seize $76 Million in Illegal Vapes From China
Roughly 3 million units were confiscated in the operation as part of a federal crackdown on illegal e-cigarettes.